Maxim Yankelevich

4PUBLICATIONS
8CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Neonatology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 22, 2024
Targeting refractory/recurrent neuroblastoma and osteosarcoma with anti-CD3×anti-GD2 bispecific antibody armed T cells.

Maxim Yankelevich, Archana Thakur, Shakeel Modak

|Feb 20, 2021
Molecular insights into malignant progression of atypical choroid plexus papilloma.

Maxim Yankelevich, Jonathan L Finlay, Hamza Gorsi

|Jul 10, 2020
Delayed Granulocyte Colony-Stimulating Factor (G-CSF) Administration after Chemotherapy Reduces Total G-CSF Doses without Affecting Neutrophil Recovery in a Randomized Clinical Study in Children with Solid Tumors.

Maxim Yankelevich, David J Hoogstra, Judith Abrams

|Dec 21, 2017
Small Split Doses of CD34+ Peripheral Blood Stem Cells to Support Repeated Cycles of Nonmyeloablative Chemotherapy.

Maxim Yankelevich, Sureyya Savasan, Igor Dolgopolov

Pageof 1

Frequent Collaborators

1 joint publications

Jonathan L Finlay

1 joint publications

Hamza Gorsi

1 joint publications

William Kupsky

1 joint publications

Daniel R Boue